Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes.

Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes.

http://www.wikidata.org/entity/Q34156462

about

Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis The Effect of Education through Short Message Service (SMS) Messages on Diabetic Patients Adherence Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes.Social determinants of health in adults with type 2 diabetes--Contribution of mutable and immutable factors.The role of the pharmacist in the management of type 2 diabetes: current insights and future directions.Efficacy of Pharmacist Based Diabetes Educational Interventions on Clinical Outcomes of Adults With Type 2 Diabetes Mellitus: A Network Meta-Analysis.Effect of pharmaceutical care interventions on glycemic control in patients with diabetes: a systematic review and meta-analysis

P2860

Q26766537-3094555A-E8F2-456A-933E-1FD707038BE4 Q33850420-6E2A1933-0469-4153-964E-1489940B30B3 Q35858560-2550891C-E32C-452E-934C-9F8AF4526E96 Q36377981-9652C955-9AD8-41C2-BDA2-CD2635ABF8E4 Q49385628-4695239B-69C6-4BE5-AAA0-633ADE569CA7 Q52564662-E659FAEC-2129-4F5E-906B-52DAA4442601 Q57490624-F47BDF8F-E2D1-4120-96C4-2B40DADC6F0D

P2860

Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes.

http://www.wikidata.org/entity/Q34156462

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@ast

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@en

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@nl

type

label

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@ast

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@en

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@nl

prefLabel

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@ast

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@en

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@nl

P1433

Q34156462-B3EAD41C-DBF1-4FBC-8D74-5F2E4AD12B7B

P1476

Q34156462-5204398F-98C2-4E0F-8546-0E5B81B0C17B

P2093

Q34156462-33DE9E1F-BC4D-4447-9BF8-63E81200BC97

Q34156462-C7AEAB7D-3A5A-4315-80C3-F8D4CD153459

Q34156462-DCE8EC31-808F-4A24-A040-549E8FEB700F

Q34156462-F54BC7C4-1AF8-4DE7-98B3-A52509100E0B

P2860

Q34156462-030DF205-D959-4E0F-9253-4FAB5747B3E5

Q34156462-09DA3F2B-E1A3-4C80-BAE1-69391E0934FB

Q34156462-0AB59933-D407-432A-BC2F-1B75D374DA58

Q34156462-0BD5CA5E-806A-4280-B6A5-DBBD3F101FA5

Q34156462-0C727D41-096E-4B6B-86B7-71BF0837EAE3

Q34156462-150A2D32-2985-4CAD-9250-61887C3FA794

Q34156462-1F4467A4-2E75-42D1-A37E-EE01EF2106B3

Q34156462-2C18E962-66D8-4962-ABDE-63126EAD61D8

Q34156462-3D798E6E-3B79-49F5-8099-8A35E1BF94D8

Q34156462-455D374C-8363-4F55-9B79-6BD3680219C6

P304

Q34156462-71A92181-D612-4E9B-B28F-1C41A68E3B2B

P31

Q34156462-CCB9188D-EC5B-4F55-8E3D-7C8C5EF52821

P356

Q34156462-393191B9-8597-4DAA-B2D4-17EA3B785BFF

P407

Q34156462-A61E947B-2073-41E2-AF89-979FB146FEBD

P478

Q34156462-E9963402-13F9-44A4-B4D5-C60F4D0E71E8

P577

Q34156462-D1C96B2E-5BEC-4AA5-8EB9-3AA6621E1875

P698

Q34156462-D5D1EDA3-54DD-434E-9016-FCA7AB708708

P921

Q34156462-E12BF9DB-2E98-4E99-80CD-5D33F4BBA9DF

P932

Q34156462-A7C46FA1-B13B-4740-AB51-13A9D426187D

P356

P1433

Patient Preference and Adherence

P1476

Effects of a pharmaceutical ca ...... f people with type 2 diabetes.

@en

P2093

Pauline Siew Mei Lai

http://www.w3.org/2001/XMLSchema#string

Siew Pheng Chan

http://www.w3.org/2001/XMLSchema#string

Siew Siang Chua

http://www.w3.org/2001/XMLSchema#string

Wen Wei Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Opportunities and responsibilities in pharmaceutical care.

Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

Addressing non-communicable diseases in Malaysia: an integrative process of systems and community.

Optimizing adherence to pharmaceutical care plans.

Obesity and diabetes in the developing world--a growing challenge.

Role of the pharmacist in diabetes management.

P304

1185-1194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/PPA.S66619

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25214772

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4159395

http://www.w3.org/2001/XMLSchema#string